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ABSTRACT
Introduction: The Structured Interview of Reported Symptoms (SIRS-2) utilizes various strategies
in the detection of simulated psychiatric disorders. The present study aimed to examine which of
these strategies proves most useful in uncovering feigned attention deﬁcit hyperactivity disorder
(ADHD) in adulthood.
Method: One-hundred seventy-one individuals instructed to feign ADHD were compared to 46
genuine patients with ADHD as well as 99 neurotypical controls in their reports provided on the
SIRS-2.
Results: Responses provided by simulators resembled those of genuine patients with ADHD on
all SIRS-2 subscales with the exception of a supplementary scale tapping Overly Speciﬁed
symptom reports, where a moderate eﬀect emerged (d = 0.88). Classiﬁcation accuracy remained
low, with particularly poor sensitivity (sensitivity = 19.30%). Sensitivity was higher when the
decision rules postulated in the ﬁrst edition SIRS were applied instead of its successor’s decision
model, yet this increase in sensitivity came at the price of unacceptably low speciﬁcity.
Conclusion: The present results call for a disorder-speciﬁc instrument for the detection of
simulated ADHD and oﬀer starting points for the development of such a tool.
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Attention-Deﬁcit/Hyperactivity Disorder (ADHD) is
among the most common neurodevelopmental condi-
tions, exerting a far-reaching impact on the lives of
many. The symptom constellation known as ADHD
encompasses hyperactivity, impulsivity, and inattention
(American Psychiatric Association, 2013) and ﬁrst
manifests in childhood. While it was long thought
that symptom presentation and hence the disorder’s
impact dissipate as children grow older, it is now well
established that symptoms persist into adulthood in a
substantial number of cases. Up to 30% of those who
experienced symptoms of ADHD in childhood still do
so in adult age (Kessler et al., 2005), suggesting that
between 1% and 6% of the adult population may be
aﬀected (Wender, Wolf, & Wasserstein, 2001).
As awareness of adult manifestations of ADHD
increased, so did a consideration of challenges unique
to these older age brackets. Alongside questions
regarding symptom severity, comorbidity, and treat-
ment options among adults with the condition
(Wender et al., 2001), the possibility of individuals
feigning it to access external gains attracted attention.
In contrast to children, who have been believed not to
be incentivized to or capable of simulating the symp-
toms of ADHD (Jasinski & Ranseen, 2011; Salekin,
Kubak, & Lee, 2008), adults may be motivated to fake
the disorder for various reasons.
Treatment options and accommodations oﬀered to
those with a diagnosis of ADHD present incentives to
malingerers. Stimulant medication, a commonly cho-
sen treatment for the condition (Sharma & Couture,
2014), has been found to improve cognitive function-
ing in people with ADHD across various domains,
such as vigilance and mental ﬂexibility (Fuermaier et
al., 2016b ; Tucha et al., 2006). Amidst heated discus-
sions surrounding “cognitive enhancement”, non-med-
ical use of this class of medication has been presumed
to result in similar beneﬁts for neurotypical individuals
CONTACT Anselm B. M. Fuermaier a.b.m.fuermaier@rug.nl University of Groningen, Faculty of Behavioural and Social Sciences, Department of Clinical and
Developmental Neuropsychology, Grote Kruisstraat 2/1, Groningen 9712 TS, The Netherlands
*These authors contributed equally to this work.
Supplementary material data can be accessed here.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
2019, VOL. 41, NO. 8, 786–802
https://doi.org/10.1080/13803395.2019.1621268
© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-
nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built
upon in any way.
(Ilieva & Farah, 2013; Smith & Farah, 2011). Despite a
lack of evidence suggesting beneﬁcial eﬀects of stimu-
lant medication among healthy adults (Hall & Lucke,
2010), these supposed favorable eﬀects on cognition
make stimulants desirable to students and professionals
alike (Rabiner, 2013; Rabiner et al., 2009; Sansone &
Sansone, 2011).
Alongside pharmaceutical interventions, accommo-
dations at school or work may be accessible to those
with ADHD (Tucha, Sontag, Walitza, & Lange, 2009).
Disability status, as granted following the diagnosis of
ADHD, can further lead to tax reductions and addi-
tional time oﬀ work (Bundesministerium der Justiz
und für Verbraucherschutz, 2016; Internal Revenue
Service, 2016). In some cases, social security beneﬁts
may follow (Pulcini et al., 2015; Steyn, Schneider, &
McArdle, 2002). Advantages of an established diagnosis
of ADHD may further extend beyond the academic or
professional domains to the forensic context, where it
may result in diminished criminal liability (for discus-
sion see Eme, 2014). Signiﬁcant rates of illicit stimulant
drug use (Advokat, Guidry, & Martino, 2008) and
increasing numbers of self-referrals for evaluations of
ADHD (Harrison, Edwards, & Parker, 2008) provide
evidence that these incentives may suﬃce to motivate
individuals to feign the condition.
While treatment options and accommodations turn
ADHD into an attractive target for individuals attempt-
ing to feign the condition, the diagnostic process makes
it a feasible diagnosis to simulate. An intricate etiology
and vague diagnostic criteria, combined with the lack of
objective diagnostic markers (Curatolo, 2005; Fuermaier
et al., 2012; Thome et al., 2012; Wankerl et al., 2014),
necessitate the reliance on a variety of instruments in the
diagnostic process. Ease of use and time constraints
encountered in clinical practice contribute to the popu-
larity of self-report measures and clinical interviews as
important parts of this process. Insights derived from
these measures may be supplemented by collateral infor-
mation gathered by interviewing examinees’ relatives or
signiﬁcant others, or by reviewing school and employ-
ment records.
Due to their central role in the diagnostic process of
ADHD, self-report measures have garnered signiﬁcant
interest with regard to their utility in detecting feigned
presentations of the disorder. Results suggest that exist-
ing self-report measures are undependable in distin-
guishing true patients with ADHD from those aiming
to simulate the condition (Bryant et al., 2018; Musso &
Gouvier, 2014; Tucha & Fuermaier, 2015), possibly due
to the highly subjective nature of the reports (Fisher &
Watkins, 2008; Jachimowicz & Geiselman, 2004;
Marshall et al., 2010). Using subsets of items from the
Conners’ Adults ADHD Rating Scale (CAARS)
(Conners, Erhardt, & Sparrow, 1999), a self-report mea-
sure commonly used in the diagnostic process, an index
has been developed for the sole purpose of diﬀerentiat-
ing genuine patients from individuals feigning ADHD
(Suhr, Buelow, & Riddle, 2011). While initially promis-
ing, examination of this Infrequency Index has yielded
mixed results (Cook et al., 2017; Cook, Bolinger, & Suhr,
2016; Edmundson et al., 2017; Fuermaier et al., 2016a;
Harrison & Armstrong, 2016; Walls, Wallace, Brothers,
& Berry, 2017). Classiﬁcation accuracy was promising,
yet further validation is needed to support the index’
clinical application.
Alongside self-report measures, clinical interviews
have been scrutinized with regard to their ability to
detect feigned conditions. The Structured Interview of
Reported Symptoms (SIRS), now in its second edition
(Rogers, Sewell, & Gillard, 2010), has been established
speciﬁcally for this purpose. Beyond good sensitivity
and speciﬁcity rates, the SIRS-2 bears the distinct
advantage of utilizing a variety of detection strategies
pertinent to the fabrication of psychiatric complaints.
Its eight primary scales capitalize on the detection of
response patterns uncommon among genuine patients
(unlikely detection strategies) as well as excessively
impaired presentations (ampliﬁed detection strategies
including ﬂoor eﬀects and symptom validity testing, i.
e., identiﬁcation based on below-chance performance)
(Rogers et al., 2010). It is a well-validated measure; its
usefulness has been attested in the detection of various
feigned psychiatric conditions, such as post-traumatic
stress disorder, schizophrenia, and mood disorders
(Freeman, Powell, & Kimbrell, 2008; Rogers, Kropp,
Bagby, & Dickens, 1992), and across ethnicities (Liu
et al., 2013; Rogers et al., 2010).
Recent research on the Structured Interview of
Reported Symptoms has, however, suggested signiﬁcant
changes in classiﬁcation accuracy from the original SIRS
publication (Rogers, Bagby, & Dickens, 1992) to the
instrument’s revised, second edition (Rogers et al.,
2010). Whereas the SIRS-2 retains the items and scoring
of the ﬁrst edition SIRS, it features new scales and indices
as well as a new classiﬁcation model. The primary goal of
these changes was the reduction of false-positive classiﬁ-
cations. Yet the comparison of both SIRS editions
strongly suggests that the SIRS-2’s improved speciﬁcity
comes at the cost of meaningfully reduced sensitivity
among forensic psychiatric patients and disability clai-
mants, as well as individuals presenting with symptoms of
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Dissociative Identity Disorder (Brand, Tursich, Tzall, &
Loewenstein, 2014; Green, Rosenfeld, & Belﬁ, 2013;
Tarescavage & Glassmire, 2016; Tylicki et al., 2018).
While the newly introduced RS Total Score (please refer
to Method Section for descriptions of the scales and
indices) appears to serve its intended purpose in reducing
false-positive rates (Green et al., 2013), the value of the
newMT Index and SS Index has been called into question
(Green et al., 2013; Tarescavage & Glassmire, 2016).
Eﬀorts made to detect feigned ADHD have gone
beyond self-report measures and clinical interviews to
examine the utility of personality inventories (Aita, Sofko,
Hill, Musso, & Boettcher, 2017; Butcher, 2009; Morey,
1991; Musso, Hill, Barker, Pella, & Gouvier, 2016; Smith,
Cox, Mowle, & Edens, 2017; Young & Gross, 2011), cog-
nitive tests as they are employed in routine neuropsycho-
logical examinations (Conners et al., 2000; Fuermaier et al.,
2018; Morey, 2016, 2017; Quinn, 2003; Suhr, Sullivan, &
Rodriguez, 2011), as well as symptom validity tests devel-
oped speciﬁcally to uncover feigned cognitive impairment
(Edmundson et al., 2017; Fuermaier, Tucha, Koerts,
Aschenbrenner, & Tucha, 2017a ; Green, 2003, 2008;
Leppma, Long, Smith, & Lassiter, 2017) in detecting simu-
lated ADHD. While these eﬀorts have yielded promising
results, evidence warranting the use of any single instru-
ment in the detection of aggravated or simulated symp-
toms is yet lacking.
Taken together, testing the validity of reported com-
plaints amongst individuals presenting for the assess-
ment of possible ADHD has been strongly advised
(Marshall, Hoelzle, Heyerdahl, & Nelson, 2016), and
the American Academy of Clinical Neuropsychology
recommends a multi-method approach in doing so
(Heilbronner, Sweet, Morgan, Larrabee, & Millis,
2009), employing multiple instruments based on dif-
ferent detection strategies (Bush et al., 2005).
The present study aims to examine the veracity of
the SIRS-2 in detecting feigned presentations of ADHD
by employing a simulation design. While the SIRS-2
has been developed to detect malingered psychiatric
complaints, rather than simulated cognitive symptoms
such as the deﬁcits in attention seen in ADHD, it bears
the distinct advantage of enquiring about various stra-
tegies used in the fabrication of such complaints. Thus,
the SIRS-2 may not be expected to distinguish between
genuine and feigned instances of ADHD at levels of
accuracy akin to those found in other psychiatric con-
ditions, such as post-traumatic stress disorder or schi-
zophrenia, yet it may oﬀer invaluable information on
detection strategies most sensitive to feigned ADHD.
In examining such strategies, possible starting points
for the development of a disorder-speciﬁc symptom




Fifty adults with ADHD took part in the study. Local
psychiatrists or neurologists referred the patients to the
Department of Psychiatry and Psychotherapy at the SHR
Clinic Karlsbach-Langensteinbach, Germany, where diag-
nostic assessments were conducted and diagnoses con-
ﬁrmed by at least two experienced clinicians. Diagnoses
of ADHD were secured through a comprehensive clinical
assessment, which included a psychiatric interview in
accordance with the DSM-IV (American Psychiatric
Association, 2000) criteria for ADHD. The interview,
devised by Barkley and Murphy (1998), encompasses
inquiry into past as well as current symptoms.
Additionally, the assessment involved the identiﬁca-
tion of objective impairments in line with the diagnosis
of ADHD, such as records of failure in school or
employment. If possible, inquiries were addressed to
multiple informants (e.g., evaluations made by employ-
ers, reports made by parents or partners). Participants
further completed two standardized self-report rating
scales measuring both past and present symptoms of
ADHD (WURS-K and ASR) (Adler et al., 2006; Kessler
et al., 2005; Ward, Wender, & Reimherr, 1993). As all
participants scored above the recommended cut-oﬀ
scores on these scales, severity of their past and present
symptoms was assumed to be clinically relevant.
All patients underwent examination of their
reported cognitive complaints to further validate the
veracity of their diagnoses and minimize the likelihood
of the patient sample including aggravated or dishonest
reports. To this end, an independent test was consulted
above and beyond the SIRS-2 examined in the study.
The Groningen Eﬀort Test (GET) (Fuermaier et al.,
2016c, 2017a) is an established instrument developed
for the detection of feigned ADHD (see Materials for
description). Three patients scored above the recom-
mended cut-oﬀ score, suggesting possible non-credible
performance. These patients were excluded from
further analyses. One additional patient had to be
excluded due to recent medication intake: the partici-
pant in question had taken stimulant medication less
than 24 h prior to their assessment.
The remaining 46 participants in the ADHD Group
were, on average, 33.85 years of age (SD = 10.66) at the
time of participation. The group’s average Intelligence
Quotient (IQ) was estimated to be 102.16 (SD = 11.92)
(see the “Materials” section for details on the instru-
ment used to estimate intellectual functioning).
Prevalence of ADHD subtypes diﬀered within the
sample of the remaining patients with the disorder: 25
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(54.35%) presented with adult ADHD of the combined
type, while 20 patients (43.48%) met the criteria for the
predominantly inattentive type. One patient (2.17%)
exhibited symptoms in line with the hyperactive-
impulsive type of ADHD.
Twenty-one patients with ADHD (45.65%) reported
psychiatric comorbidities, eight of whom presented
with more than one comorbid psychiatric disorder.
Depression was most commonly reported (n = 16),
four patients indicated a comorbid anxiety disorder.
Five patients had been diagnosed with a personality
disorder. Two participants reported a history of sub-
stance abuse, with no such abuse in the past six
months. Eating disorders (n = 2), post-traumatic stress
disorder (n = 1), and somatoform disorder (n = 1),
while less common, were also reported. Since psychia-
tric comorbidities are highly prevalent among adults
with ADHD (Biederman et al., 1993), participants with
such additional disorders were not excluded from the
current study.
Healthy individuals
Matched control group. Recruited through public
announcements, researchers’ contacts, and word-of-
mouth, 46 neurotypical individuals were matched to
the ADHD Group according to age, gender, and intel-
lectual functions. These participants formed the
Matched Control Group, whose descriptive statistics
can be found in Table 1. This group was included to
determine whether diagnostic status is associated with
diﬀerential responses to SIRS-inquiries: to answer the
question, whether adults with ADHD diﬀer from adults
without the condition in their responses to SIRS-items,
we matched this Control Group with regard to age,
gender, and estimated IQ.
Healthy comparison individuals did not diﬀer signiﬁ-
cantly from adults with ADHDwith regard to age (t(90) =
−0.328; p = .744), gender (χ2(1) = 1.0; p = 1.0), or intellec-
tual functions (t(89) = −1.118; p = .267). However, healthy
comparison individuals diﬀered signiﬁcantly from adults
with ADHD with regard to self-reported past (t(66.297) =
14.186; p < .001) and present (t(71.592) = 20.015; p < .001)
symptoms of ADHD. As expected, patients endorsed
higher symptomatology on both accounts than their
matched neurotypical peers did.
Healthy student group. The original sample of neuro-
typical volunteers encompassed 293 ﬁrst-year psychol-
ogy students at the University of Groningen, The
Netherlands, who participated in exchange for course
credit. Following the assessment, 69 of these student
volunteers had to be excluded from further analyses
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ADHD symptoms, as measured by self-report on two
standardized scales tapping past and present symptoms
of ADHD (WURS-K and ASR) (Adler et al., 2006;
Kessler et al., 2005; Ward et al., 1993). The remaining
healthy student group consisted of 224 participants
with an average age of 21.99 years (SD = 4.13) and
an estimated IQ of 99.92 (SD = 8.74). A total of 170
individuals within the student sample identiﬁed as
female, 54 were male. These participants were ran-
domly allocated to one of four conditions within the
healthy student group: an Experimental Control Group
and three simulation conditions, encompassing a Naïve
Simulation Group, a Symptom-Coached Simulation
Group, and a Test-Coached Simulation Group. These
groups were included to examine whether the instruc-
tion to feign symptoms of ADHD altered participants’
responses to SIRS inquiries (i.e., manipulation check).
Descriptive statistics for all groups, as well as self-
reported levels of past and present ADHD symptoma-
tology, may be found in Table 1.
The Experimental Control Group encompassed 53
students with a mean age of 22.74 years (SD = 4.71)
and a mean IQ of 99.06 (SD = 8.36). Simulation groups
were composed as follows: the Naïve Simulation Group
included 55 participants, 60 participants belonged to
the Symptom-Coached Simulation Group, and the Test-
Coached Simulation Group included 56 participants.
These groups of healthy individuals were compar-
able with regard to age (F(3,218) = 23.288, p = .253),
sex (χ2(3) = 6.122, p = .106), and estimated intelli-
gence (F(3,188) = 0.804, p = .493). None of the healthy
individuals reported a history of neurological or psy-
chiatric disorders and none had taken or were taking




The short version of the Wender Utah Rating Scale
(WURS-K) was used to measure childhood symptoms
of ADHD (Ward et al., 1993). The scale encompasses
25 items which are rated on a ﬁve-point scale.
Participants indicated the current severity of ADHD
symptoms by means of the ADHD Self-Report Scale
(ASR) (Adler et al., 2006; Kessler et al., 2005), which
includes 18 items rated on a four-point scale. Items
correspond to the diagnostic criteria for ADHD
as deﬁned in the DSM-IV (American Psychiatric
Association, 2000). Sum scores were calculated for
both rating scales.
Structured interview of reported symptoms (SIRS-2)
The SIRS-2 is a 172-item interview designed to uncover
response styles common among those exacerbating or
feigning symptoms, each of which is examined in one
of eight primary scales: Rare Symptoms (RS), Symptom
Combinations (SC), Improbable or Absurd Symptoms
(IA), Blatant Symptoms (BL), Subtle Symptoms (SU),
Selectivity of Symptoms (SEL), Severity of Symptoms
(SEV), and Reported vs. Observed Symptoms (RO).
According to Rogers (2008b), two broad categories of
detection strategies form the conceptual basis on which
each of these response styles is uncovered. Some SIRS-2
scales (i.e. RS, SC, IA, and RO) are based on so-called
unlikely detection strategies, which aim to identify
simulators by the presence of symptoms not commonly
reported by genuine patients. Ampliﬁed detection stra-
tegies (i.e. BL, SU, SEL, and SEV scales), on the other
hand, encompass plausible items which simulating par-
ticipants endorse to a larger extent than individuals
with a genuine disorder.
If participants answer an inquiry with a “Deﬁnite Yes”,
the answer is scored ‘2ʹ. Answers of “Qualiﬁed Yes/
Sometimes” are given a score of ‘1ʹ, whereas “No” is
scored as ‘0ʹ. If no answer is given, “X” is scored for the
item in question. Sum scores are calculated and subse-
quently categorized as falling into the “genuine”, “prob-
able feigning” or “deﬁnite feigning” range for each of the
separate scales. The primary scales are complemented by
supplementary scales and index scores aiming to provide
further clinical descriptions. Alongside sum scores
intended to enable the classiﬁcation of the examinee’s
response style, these scales tap honesty towards mental
health professionals, defensiveness, and consistency of
symptom reports across time. All items, as well as the
scoring method, are equivalent to those of the original
SIRS (Rogers et al., 1992).
By following a decision model introduced in the
interview’s manual, the SIRS-2 allows for dichotomous
distinctions between genuine responding and probable
or deﬁnite feigning (Rogers et al., 2010). A three-tiered
process is used to reach such a classiﬁcation. As illu-
strated on the right-hand side in Figure 1, this process
considers the primary scales ﬁrst, followed by the eva-
luation of three diﬀerent sum scores (RS Total, MT
Index, and SS Index).
The SIRS-2 has demonstrated good validity and relia-
bility. Internal consistency is high for the primary scales
with coeﬃcient alphas ranging from .77 to .92, as is
interrater reliability (weighted averages ranging between
α = .95 to α = 1.00, with a mean of α = .98) (Rogers et al.,
2010). Standard errors of measurement (SEM) further
suggest high reliability of individual measurements.
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Consideration of test–retest reliability ought to be more
diﬀerentiated: whereas overall test–retest reliability was
robust (r = .82 for SIRS-2 Total Score) and satisfactory for
most scales (Mean r = .77), signiﬁcant ﬂuctuations can be
observed on a number of scales. In particular, the
Symptom Combinations (SC), Improbable or Absurd
Symptoms (IA), and Reported vs. Observed Symptoms
(RO) Scales may be subject to marked ﬂuctuations across
testing sessions. Concordance across repeated testing ses-
sions is, however, high when considering categorization
of examinees; there is high agreement in the dichotomous
decision of “feigning” or “non-feigning”.
Measures of validity also yield satisfactory results, with
convergent validity showing consistent, moderately strong
associations with other measures of simulated mental dis-
orders such as the Minnesota Multiphasic Personality
Inventory (Butcher, 2009) and the Personality
Assessment Inventory (Morey, 1991). Discriminant valid-
ity with these measures has been established. Criterion-
related validity, as measured by means of eﬀect sizes and
accuracy of individual classiﬁcation, is good (Rogers et al.,
2010).
Groningen eﬀort test
Patients’ veracity was assessed by means of the Groningen
Eﬀort Test (Fuermaier et al., 2016c, 2017a). The GET was
developed to enable the detection of non-credible perfor-
mance within the diagnostic process of ADHD. The
computerized test requires participants to solve a visual
discrimination task designed to appear cognitively taxing,
with high demands being exerted on attention and con-
centration. Most individuals, including those with
ADHD, complete the task with ease. Even so, participants
are reminded of the test’s supposed signiﬁcant cognitive
demands throughout testing. Mean response times and
number of errors (block-wise) are registered as outcome
variables. A respective cut-oﬀ score allows for the discri-
mination between credible and non-credible performance
with a high degree of accuracy. At the recommended cut-
oﬀ score, the GET’s sensitivity amounts to 89% and its
speciﬁcity to 89.5% (Fuermaier et al., 2017b). Given this
high classiﬁcation accuracy, the original cut-oﬀ score was
retained, rather than choosing a lower cut-oﬀ value which
would have maximized sensitivity to possible feigning.
This approach was chosen as lowering the cut-oﬀ score
would have resulted in undue loss of speciﬁcity, power,
and generalizability of the results.
Intellectual functions
Intellectual functions were estimated using Lehrl’s
Multiple Choice Vocabulary Test (Lehrl, Triebig, &
Fischer, 1995). The test requires participants to ﬁnd an
authentic target word among three ﬁctitious distractor
words. Answers are indicated by underlining the target
word in each of the test’s 37 lines. Scores, as derived by
summing all correct responses, oﬀer a valid quantiﬁcation
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n - 737 Indeterminate
21 Genuine
Figure 1. Comparison of classiﬁcations yielded by original SIRS decision rules (Rogers, Bagby, et al., 1992) and SIRS-2 decision model
(Rogers et al., 2010) for simulating participants (n = 145).
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Design and procedure
Assessment of ADHD group
Patients with adult ADHD were tested individually. They
received no reward for participation. Written informed
consent was sought from all patients; they were assured
that all data collected as part of the research project would
be analyzed anonymously, and that these data would not
aﬀect clinical assessment or treatment. Patients under-
went a comprehensive assessment including standard
measures of cognition, a measure of performance validity
(i.e., the GET), self-report questionnaires, and the SIRS-2.
Completion of the assessment battery took a total of 2 h,
divided into two parts to avoid potential eﬀects of fatigue
(Lezak, Howieson, Loring, Hannay, & Fischer, 2004). The
study complied with the ethical standards of the Helsinki
Declaration and was approved by the local institutional
ethical committee (Medical Faculty at the University of
Heidelberg, Germany).
Assessment of healthy participants
All healthy participants gave written informed consent
and were subsequently tested individually in a quiet
laboratory. Descriptive and anamnestic information was
collected at the beginning of the experiment, prior to the
simulation groups being instructed to feign ADHD.
Inquiries were made into information such as age, sex,
intellectual functions, and self-reported ADHD symptom
severity. Additionally, participants were asked about any
history of psychiatric or neurological disease, as well as
pharmacological treatment. The remainder of the experi-
ment diﬀered between the groups (Matched Comparison
Group and Healthy Student Group allocated either to the
Experimental Control Group, Naïve Simulation Group,
Symptom-Coached Simulation Group, or Test-Coached
Simulation Group), with diﬀerent instructions being
given to each. The assessment procedure for healthy
participants was approved by the Ethical Committee
Psychology (ECP) at the University of Groningen.
Matched control group and experimental control
group
Participants in the Matched Control Group and the
Experimental Control Group were instructed to complete
all measures, including the SIRS-2, honestly and to the
best of their ability. A day before the assessment, they
received an e-mail containing information about the
study’s clinical signiﬁcance, but not about its aim.
Assessment of a participant took approximately 50 min.
Simulation groups
Participants allocated to either of the three simulation
groups (naïve, symptom-coached, or test-coached)
were instructed to feign adult ADHD while complet-
ing the SIRS-2. To ease participants’ adaptation of
their roles as adults with ADHD, they were provided
with a vignette describing multiple possible incentives
(e.g., ﬁnancial, educational, or vocational accommo-
dations; the prescription of stimulant medication to
foster performance at school or work or for recrea-
tional use) for someone to feign the condition. The
vignette did not contain any information on the
symptoms or the nature of ADHD. Participants were
further explicitly asked to provide believable answers,
that is, to feign ADHD in a realistic manner (e.g.,
avoiding pronounced exaggeration of symptoms). As
external incentives have proven eﬀective in simulation
designs (Dunn, Shear, Howe, & Ris, 2003; Rogers,
Harrell, & Liﬀ, 1993), participants were promised the
chance of winning a tablet PC if they feigned the
condition most convincingly. Unbeknownst to parti-
cipants and in line with ethical considerations, the PC
was awarded to a participant chosen at random (i.e.,
irrespective of test performance) from any of the
experimental groups.
Information provided next to the vignette diﬀered
between groups (an overview can be found in Table 2).
TheNaïve Simulation Group received no further informa-
tion and no further suggestions on how to feign ADHD
convincingly. Symptom-coached participants were pro-
vided descriptions of ADHD symptoms as laid out by the
DSM-IV (American Psychiatric Association, 2000),
equipping participants with enough information to
become familiar with the clinical presentation of ADHD
(Tucha et al., 2009). Finally, the Test-Coached Group of
feigning participants was given information on various
detection strategies used to uncover feigning. This group
received information on general characteristics of neu-
ropsychological assessment, including the role of inter-
views in the diagnostic process.
Table 2. Information and instructions provided to each group.
Vignette Information on Symptoms Information on Assessment Methods Instruction
ADHD Group No No No Honest responding
Matched Control Group No No No Honest responding
Experimental Control Group No No No Honest responding
Naïve Simulation Group Yes No No Feign adult ADHD
Symptom-Coached Simulation Group Yes Yes No Feign adult ADHD
Test-Coached Simulation Group Yes Yes Yes Feign adult ADHD
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To allow participants suﬃcient time to prepare strate-
gies for the successful fabrication of symptoms of adult
ADHD, information was provided twice; once via mail the
day before participation and at the beginning of the assess-
ment. Before the assessment began, participants in both
the Symptom- and the Test-Coached Groups answered
questions regarding the information they had been pro-
vided with. All participants were able to answer these
correctly, so that no participants had to be excluded.
Participants were subsequently asked to begin feigning
adult ADHD, answering the remainder of the assessment
as though they suﬀered from the disorder. After the assess-
ment, participants were instructed to stop feigning the
condition. They were debriefed and asked whether they
had followed the given instructions accordingly, including
the one asking them to feign ADHD. All participants
answered in the aﬃrmative. Assessment of the simulation
groups took 70 min. Administrators were aware of the
instructions each participant had previously received.
Results
Classiﬁcation rates based on SIRS and SIRS-2
decision rules
Participants’ responses were ﬁrst classiﬁed on the basis
of the updated decision model outlined in the SIRS-2
manual (Rogers et al., 2010; see right-hand side of
Figure 1). As illustrated in Table 3, this model correctly
classiﬁed 73.91% of adults with ADHD (n = 34) as
genuine responders. Misclassiﬁcation of genuine
patients as “Feigning” occurred in 6.52% (n = 3) of
cases. A total of 33 instructed simulators (19.30%) were
correctly identiﬁed as such, whereas 59.06% of simulat-
ing participants (n = 101) were incorrectly classiﬁed as
honest responders (“Genuine” classiﬁcation).
As measures of classiﬁcation accuracy, including
estimates of sensitivity and speciﬁcity, necessitate a
dichotomous classiﬁcation of either “genuine” or
“feigning” (see Green et al., 2013), participants classi-
ﬁed as “Indeterminate-General” and “Indeterminate-
Evaluate” were combined with the “Genuine”
responding group to determine accuracy of classiﬁca-
tion using the SIRS-2 decision model. This yielded a
sensitivity of .19 and a speciﬁcity of .93. To account
for the increased chance of feigning among
individuals classiﬁed as “Indeterminate-Evaluate”
(Rogers et al., 2010), accuracy rates were also calcu-
lated when counting participants with an
“Indeterminate-Evaluate” classiﬁcation towards the
“Feigning” cases. Using this approach, sensitivity
amounted to .24, speciﬁcity equaled .89.
Estimates of sensitivity and speciﬁcity were further
calculated in the manner described by Rogers (2010),
whereby all “Indeterminate” cases are excluded before
carrying out the calculations. Doing so resulted in the
exclusion of nine patients and 37 simulators, a sensi-
tivity of .25, and speciﬁcity of .92.
Responses provided by 289 participants were re-evalu-
ated according to the ﬁrst edition of the SIRS’ professional
manual (Rogers et al., 1992; left-hand side of Figure 1).
Classiﬁcations based on the original manual were missing
for 26 simulating participants and one honest responding
neurotypical control, as SIRS Total Scores could not be
retrieved for these cases. Applying the decision rules
described in the original professional manual, 23.91% (n
= 11) of patients with ADHD were correctly identiﬁed as
honest responders (see Table 3). Fifteen adults with
ADHD (32.61%) were wrongfully classiﬁed as “Feigning”
based on the SIRS. Among members of the Combined
Simulation Group, 60% of cases were correctly identiﬁed
to be “Feigning” (n = 87). Misclassiﬁcation as honest
responding (“Genuine” classiﬁcation) occurred in 14.48%
of cases (n = 21).
Sensitivity and speciﬁcity were calculated for classiﬁca-
tions produced by the original decision rules in the same
manner as those yielded by the second edition’s decision
model. Considering “Indeterminate” cases not to be feign-
ing resulted in a sensitivity of .60 and a speciﬁcity of .67. If
“Indeterminate” cases were instead considered to be feign-
ing, sensitivity amounted to .86, speciﬁcity to .24.
Excluding “Indeterminate” cases, as illustrated by Rogers
(2010), before calculating accuracy estimates resulted in a
sensitivity of .81 and a speciﬁcity of .42. In doing so, data of
20 patients and 37 simulators were excluded.
Comparison of SIRS and SIRS-2 classiﬁcations
Classiﬁcations derived from the SIRS and the SIRS-2
coincided for 56.75% of the 289 participants (see
Supplementary Table 2) when “Indeterminate” SIRS-2
classiﬁcations (i.e., “Indeterminate-General” and
Table 3. Agreement of SIRS classiﬁcation and group membership.
SIRS Classiﬁcation SIRS-2 Classiﬁcation
Group Genuine Indeterminate Feigning Genuine Indeterminate-General Indeterminate-Evaluate Feigning
ADHD Group 11 (23.91%) 20 (43.48%) 15 (32.61%) 34 (73.91%) 7 (15.22%) 2 (4.35%) 3 (6.52%)
Combined Simulation Group 21 (14.48%) 37 (25.52%) 87 (60%) 101 (56.06%) 29 (16.96%) 8 (4.68%) 33 (19.30%)
Combined Control Group 93 (94.90%) 4 (4.08%) 1 (1.02%) 98 (99%) 1 (1%) 0 (0%) 0 (0%)
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“Indeterminate-Evaluate”) were collapsed into one
category. Agreement was perfect for participants
whose responses yielded a “Genuine” classiﬁcation
based on the original SIRS decision rules, as all of
them were sorted into the same category on the SIRS-
2 (n = 125, 100%). The number of “Feigning” classiﬁ-
cations, however, decreased from 103 to 36 when scor-
ing answers according to the SIRS-2 rather than the
SIRS. Thirty participants (29.13%), whose answers
resulted in a SIRS-based “Feigning” classiﬁcation,
were sorted into the “Genuine” category by the SIRS-
2 decision rules. The remaining SIRS-identiﬁed feign-
ing participants were moved into “Indeterminate-
General” (n = 29, 28.16%) or “Indeterminate-
Evaluate” (n = 8, 7.77%) classiﬁcations based on the
SIRS-2.
Agreement between the two SIRS editions was high-
est amongst honest-responding neurotypical controls (n
= 98), with classiﬁcations coinciding in 94.90% of cases
(n = 93). Classiﬁcations yielded by the SIRS and SIRS-2
agreed in 39.31% of cases in the Combined Simulation
Group (n = 145). Discordance occurred primarily for
participants who were classiﬁed as “Feigning” based on
the original SIRS decision rules (n = 87). Twenty-seven
(31.03%) of these initially correctly identiﬁed simulators
were considered to be honest responders based on the
SIRS-2 decision model. Additional 31% (n = 27) were
categorized as “Indeterminate” on the SIRS’ second edi-
tion. Accordingly, 37.93% (n = 33) of simulators who
had been correctly identiﬁed by the SIRS were also
regarded as “Feigning” on the SIRS-2. Considering the
group of adults with ADHD (n = 46), classiﬁcations
based on the SIRS and SIRS-2 converged in 30.43% of
cases. Discrepancies largely arose as all “Indeterminate”
cases brought forward by the SIRS decision rules fell
into the “Genuine” category when the SIRS-2 decision
model was applied (n = 20, 100%). Additionally, 12
patients with ADHD considered to be “Feigning” by
SIRS standards were sorted into the “Genuine” (n = 3,
20%) or “Indeterminate” (n = 9, 60%) categories on the
SIRS-2.
All agreement rates, as well as further information
on the distribution of the SIRS Total, RS Total, and MT
Index may be found in the Supplementary Material.
Experimental analyses of SIRS-2 subscales across
groups
Means and standard deviations of SIRS-2 scores by group
can be found in Table 4. Supplementary Table 1 further
lists SIRS-2 scores for each of the three stimulation condi-
tions, which did not diﬀer signiﬁcantly from one another
(p > .011 for all SIRS-2 scales). A Bonferroni-corrected
signiﬁcance level of p = .05/16 = .003 was considered in
the interpretation of all null hypothesis signiﬁcance tests to
account for multiple comparisons. Given the previously
described sample sizes for patients with ADHD (n = 46)
and simulators (n = 171), this adjusted signiﬁcance level
was associated with a power of 0.96 or larger for eﬀect sizes
of d ≥ 0.75. In accordance with Roger’s classiﬁcation of
eﬀect sizes inmalingering research (Rogers, 2009), an eﬀect
of this size (i.e., ≥0.75) was considered a moderate one.
Values ≥1.25 were considered large, whereas those ≥1.5
were deemed very large.
The comparison of item endorsement (Kruskal–Wallis
Test) revealed signiﬁcant diﬀerences between groups on








(n = 171) H (df) p
RS 1.91 (2.49) 0.63 (0.99) 0.42 (0.82)b 3.05 (2.95) 76.67 (5) <.001
SC 1.72 (1.22) 0.39 (0.77)a 0.42 (0.84)b 3.73 (3.15)a 119.14 (5) <.001
IA 0.41 (0.75) 0.59 (2.96) 0.04 (0.28)b 1.05 (1.88) 34.69 (5) <.001
BL 5.37 (4.29) 0.48 (1.21)a 0.55 (0.85)b 4.99 (3.84) 137.77 (5) <.001
MT 9.41 (6.62) 2.09 (3.78)a 1.38 (1.80)b 12.82 (10.11) 142.87 (5) <.001
SU 14.00 (5.57) 2.98 (3.05)a 3.00 (2.38)b 16.32 (5.16)a 193.23 (5) <.001
SEL 14.02 (4.54) 3.07 (2.95)a 3.32 (2.51)b 14.32 (4.34) 178.34 (5) <.001
SEV 5.33 (5.53) 0.39 (1.11)a 0.21 (0.60)b 6.51 (4.58) 141.36 (5) <.001
RO 3.00 (1.89) 0.72 (1.31)a 1.36 (2.08)b 4.87 (5.46) 63.69 (5) <.001
RS-T 3.70 (2.40) 1.15 (1.09)a 1.15 (1.05)b 4.51 (3.63) 104.77 (5) <.001
DA 3.85 (2.62) 2.70 (1.74)c 2.32 (1.45)c 3.58 (3.06)c 10.93 (5)c .053
DS 25.50 (5.91) 17.48 (6.29)a 16.96 (6.09)b 26.07 (6.78) 91.40 (5) <.001
IF 2.37 (1.55) 1.00 (0.92)a 1.06 (0.95)b 2.39 (2.22) 49.02 (5) <.001
OS 0.02 (0.15) 0.24 (0.64) 0.15 (0.46)b 1.51 (1.90)a 86.69 (5) <.001
SS 31.74 (7.49) 21.41 (6.93)a 20.49 (6.66)b 33.56 (8.64) 144.89 (5) <.001
INC 1.48 (1.67) 0.59 (1.20)a 0.58 (1.46)b 2.69 (2.56)a 81.96 (5) <.001
SIRS, Structured Interview of Reported Symptoms; RS, Rare Symptoms; SC, Symptom Combinations; IA, Improbable or Absurd Symptoms; BL, Blatant
Symptoms; MT (Modiﬁed Total Index), sum score of RS, SC, IA, and BL items; SU, Subtle Symptoms; SEL, Selectivity of Symptoms; SEV, Severity of
Symptoms; RO, Reported vs. Observed Symptoms; RS-T (RS-Total), Rare Symptoms sum score; DA, Direct Appraisal of Honesty; DS, Defensive Symptoms; IF,
Improbable Failure; OS, Overly Speciﬁed Symptoms; SS (SS Index), sum score encompassing DA, DS, IF, and OS items; INC, Inconsistency of Symptoms.
aStatistically signiﬁcantly diﬀerent from ADHD Group; bStatistically signiﬁcantly diﬀerent from Combined Simulation Group; cNo pairwise comparisons
calculated, as Kruskal–Wallis Test did not reach signiﬁcance.
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all scales, but the index tapping Direct Appraisals of
Honesty (DA) (H(5) = 10.93, p = .053) (see Table 4).
Follow-up analyses (Mann–Whitney U Tests) were con-
ducted to investigate pairwise comparisons.
Comparison of ADHD group and combined
simulation group
The Combined Simulation Group diﬀered signiﬁcantly
from adults with ADHD on four SIRS-2 scales. On
scales assessing Symptom Combinations (SC) (U =
2421.50; p < .001; d = 0.70), Subtle Symptoms (SU)
(U = 2806.00; p = .003, d = 0.44), Overly Speciﬁed
Symptoms (OS) (U = 1706.50; p < .001, d = 0.88), or
Inconsistency of Symptoms (INC) (U = 2701.50; p <
.001; d = 0.51), simulators’ responses yielded signiﬁ-
cantly higher scores than those of adults with ADHD.
No statistically signiﬁcant diﬀerences were detected
between the groups on any of the remaining scales (p
≥ .005; 0.01 ≤ d ≤ 0.40). The magnitude of diﬀerences
between patients and simulators was negligible: most
comparisons between patients and simulators yielded
trivial eﬀect sizes (see Table 5 and Figure 2 for 95%-
conﬁdence intervals around the eﬀect sizes). The sup-
plementary scale examining the report of Overly
Speciﬁed Symptoms (OS) presented the sole excep-
tion with a moderate eﬀect based on Roger’s classiﬁ-
cation (d = 0.88; 95%CI[0.55, 1.22]). Endorsement of
individual items composing this scale was further
compared between the ADHD Group and the
Combined Simulation Group. The sum score for the
OS scale is attained by summing up responses pro-
vided to seven items (items number 24, 33, 41, 110,
114, 119, and 135). As illustrated in Figure 3, adults
with ADHD did not endorse any item belonging to
this scale. Among simulating participants, endorse-
ment of item number 135 was most common (“Do
you spend much time worrying about your physical
health? Would this average between 30 and 40 min
each day?”). Supplementary Table 3 presents results
of a ROC analysis, which provided limited support
for the diagnostic accuracy of the OS scale.
Table 5 illustrates signiﬁcant diﬀerences found
between patients with ADHD and their neurotypical
counterparts on most SIRS-2 scales, which arose
because adults with ADHD endorsed – on average –
higher levels of symptomatology than their matched
peers. It further shows signiﬁcant diﬀerences between
the Combined Simulation Group and Experimental
Control Group, which conﬁrm that the instruction to
feign ADHD successfully altered the participants’
responding behavior.
Discussion
Its consideration of various detection strategies consti-
tutes one of the SIRS’ strengths, and has allowed the
present study to examine the utility of these very stra-
tegies in the detection of feigned adult ADHD. Herein,
the focus lay on determining which detection strategies




(n = 46) vs.
Matched Control Group
(n = 46)




(n = 46) vs.
Combined Simulation Group
(n = 171)
U p d U p d U p d
RS 749.00 .009 0.67 1618.50 <.001 1.01 2886.00 .005 0.40
SC 421.00 <.001 1.30 1221.50 <.001 1.19 2421.50 <.001* 0.70
IA 920.50 .120 0.08 2892.00 <.001 0.61 3339.00 .066 0.37
BL 213.00 <.001 1.55 885.00 <.001 1.31 3744.50 .617 0.10
MT 213.00 <.001 1.36 569.00 <.001 1.29 3232.00 .063 0.36
SU 71.50 <.001 2.45 118.50 <.001 2.86 2806.00 .003* 0.44
SEL 63.00 <.001 2.86 278.00 <.001 2.76 3771.50 .668 0.07
SEV 394.00 <.001 1.24 668.00 <.001 1.57 3193.50 .050 0.25
RO 339.50 <.001 1.40 2395.50 <.001 0.72 3600.00 .375 0.38
RS-T 330.00 <.001 1.37 1436.00 <.001 1.05 3623.00 .409 0.24
DA – – – – – – – – –
DS 380.00 <.001 1.32 1440.00 <.001 1.38 3668.50 .484 0.09
IF 427.50 <.001 1.07 2805.00 <.001 0.67 3536.50 .285 0.01
OS 940.50 .046 0.48 2275.00 <.001 0.81 1706.50 <.001* 0.88
SS 333.50 <.001 1.43 1053.00 <.001 1.58 3424.00 .178 0.22
INC 656.50 .001 0.61 1719.50 <.001 0.91 2701.50 .001* 0.51
RS, Rare Symptoms; SC, Symptom Combinations; IA, Improbable or Absurd Symptoms; BL, Blatant Symptoms; MT (Modiﬁed Total Index), sum score of RS, SC,
IA, and BL items; SU, Subtle Symptoms; SEL, Selectivity of Symptoms; SEV, Severity of Symptoms; RO, Reported vs. Observed Symptoms; RS-T (RS-Total),
Rare Symptoms sum score; DA, Direct Appraisal of Honesty; DS, Defensive Symptoms; IF, Improbable Failure; OS, Overly Speciﬁed Symptoms; SS (SS Index),
sum score encompassing DA, DS, IF, and OS items; INC, Inconsistency of Symptoms.
*Statistically signiﬁcant diﬀerences between genuine patients with ADHD and instructed simulators at a signiﬁcance level of p ≤ .003; no pairwise
comparisons were conducted for the DA scale, as the Kruskal–Wallis Test did not reach signiﬁcance for this scale.
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included in the SIRS-2 are most suitable for distin-
guishing genuine from simulated adult manifestations
of ADHD.
Application of the decisionmodel described in the SIRS-
2 manual (Rogers et al., 2010) resulted in isolated misclas-
siﬁcation of genuine cases ofADHDandpoor classiﬁcation
rates among simulators. Whereas the majority of genuine
patients was classiﬁed as such, a considerable minority was
categorized as “Indeterminate”. Two adults with ADHD
were falsely assumed to be feigning their complaints.
Further, mere 19.3% of instructed simulators were
detected. The majority of simulators (59.1%) was incor-
rectly classiﬁed as honest responders. Thus, sensitivity was
low, with estimates ranging from .19 if “Indeterminate”
cases were counted towards the “Genuine” classiﬁcations
and .25 if Rogers’ approach,whereby “Indeterminate” cases
are excluded before sensitivity is calculated, was applied.
Clearly, either estimate deviates from the sensitivity of .80
listed in the instrument’s manual (Rogers et al., 2010).
Speciﬁcity, on the other hand, was high, with estimates
ranging from .89 to .93.
A diﬀerent pattern emerged when responses were
categorized according to the decision rules outlined in
the ﬁrst edition’s manual (Rogers et al., 1992) rather than
the SIRS-2’s revised decision model. Sensitivity was gen-
erally higher than that observed for the SIRS’ second
edition, ranging from .60 if “Indeterminate” cases were
considered not to be feigning and .86 if those with an
“Indeterminate” classiﬁcation were counted towards the
“Feigning” cases. This is in line with previous research
reporting signiﬁcant decrements in sensitivity when the
SIRS-2 is compared to its predecessor (Brand et al., 2014;
Green et al., 2013; Tarescavage & Glassmire, 2016; Tylicki
et al., 2018). As approximately 30% of adults with ADHD
were wrongfully accused of feigning; however, speciﬁcity
of the original SIRS was unacceptably low (.24 to .67).
Whereas the SIRS and its successor were in perfect
agreement in cases of SIRS-identiﬁed honest responders,
Figure 2. Ninety-ﬁve percent conﬁdence intervals for eﬀect sizes (Cohen’s d) yielded by the comparison between adults with ADHD
and the combined simulation group.
Notes: y-Axis denotes SIRS scales; x-Axis displays eﬀect sizes (Cohen’s d); dashed vertical line indicates Roger’s standard for medium eﬀect size (d = 0.75); RS
– Rare Symptoms; SC – Symptom Combinations; IA – Improbable or Absurd Symptoms; BL – Blatant Symptoms; MT (Modiﬁed Total Index) – sum score of RS,
SC, IA, and BL items; SU – Subtle Symptoms; SEL – Selectivity of Symptoms; SEV – Severity of Symptoms; RO – Reported vs. Observed Symptoms; RS-T (RS-
Total) – Rare Symptoms sum score; DA – Direct Appraisal of Honesty; DS – Defensive Symptoms; IF – Improbable Failure; OS – Overly Speciﬁed Symptoms;
SS (SS Index) – sum score encompassing DA, DS, IF, and OS items; INC – Inconsistency of Symptoms.
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drastically reduced numbers of “Feigning” classiﬁcations
upon application of the SIRS-2 resulted in an overall
convergence of 56.75%. The majority of SIRS-identiﬁed
feigners (62.07%) was detected based on relevant eleva-
tions on the primary scales, while the remaining 37.93%
were classiﬁed as “Feigning” due to SIRS Total scores
above the recommended cut-oﬀ value. The additional
classiﬁcations steps introduced with the advent of the
SIRS-2 served their intended purpose of reducing the
false-positive rate in that ﬁve adults with ADHD avoided
a wrongful “Feigning” classiﬁcation due to an unremark-
able RS Total score. Twenty-one simulators, on the other
hand, went undetected despite relevant elevations on the
primary scales since their RS Total scores did not exceed
the recommended cut-oﬀ value. In line with previous
research (Tarescavage & Glassmire, 2016), the value of
the newly introduced MT Index appeared limited. Only
one simulator scored above the cut-oﬀ score suggested by
Rogers and colleagues to be indicative of feigning. The
overall distribution of MT Index scores provides further
evidence suggesting that the recommended cut-oﬀ scores
may be inadequate (see Supplementary Material): a score
of 13 corresponded to the 60th percentile in the present
sample, whereas a score of 22 was equivalent to the 85th
percentile, and an MT Index score of 45 equaled the 99th
percentile. The SS Index was not further examined as all
participants produced unremarkable scores. In sum,
these ﬁndings underscore the urgency with which the
instrument’s authors caution against the SIRS’ applica-
tion to disorders other than those described in its manual
(Rogers et al., 2010). This may hold particularly true for
disorders manifesting primarily in cognitive dysfunction,
such as the attention deﬁcits seen in ADHD.
Exploratory comparisons of genuine patients with
ADHD and simulators suggested that responses pro-
vided by simulators closely resembled those of genuine
patients with ADHD on most scales. Considering indi-
vidual SIRS-2 scales, comparisons between patients
with ADHD and a combined group of simulators
who received various types and levels of instructions
yielded mostly non-signiﬁcant diﬀerences between the
groups, with most eﬀects failing to meet an eﬀect size
that is considered moderate in the ﬁeld of malingering
research (i.e., d > 0.75 according to Roger’s standard,
2008b). A supplementary scale assessing report of
Overly Speciﬁed Symptoms (OS) emerged as a sole
exception, resulting in not only statistically signiﬁcant
diﬀerences between the groups but also a moderate
eﬀect by the aforementioned standards. The primary
scale aiming to uncover simulated symptom reports
based on the endorsement of unusual symptom com-
binations (SC), while also yielding signiﬁcant diﬀer-
ences between genuine and simulated cases, narrowly
failed to meet Roger’s requirements for a satisfactory
eﬀect. The largest eﬀect found in the present study thus
concerned the OS scale and arose, as patients with
ADHD endorsed its items to a similar degree as their
matched neurotypical peers, whereas individuals feign-
ing the condition tended to endorse items composing
this scale to a larger extent. As exempliﬁed by other
Figure 3. Percentage of participants endorsing items composing the Overly Speciﬁed Symptoms (OS) Scale by ADHD group and
combined simulation group.
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SIRS-2 scales (e.g., BL, MT, SU, SEL, SEV and RO
scales), patients provided answers which resulted in
higher scores than those given by healthy controls.
This was not the case on the OS scale, where adults
with ADHD did not diﬀer from matched neurotypical
controls. Simulators, on the other hand, exaggerated
their accounts, thus resulting in a moderate eﬀect when
compared to genuine patients.
Upon examination of each individual item contri-
buting to the OS scale, it became apparent that simu-
lators more frequently deemed the enquiries into
overly speciﬁed symptoms as applicable to ADHD
than genuine patients with ADHD report such symp-
toms. Approximately one-third of simulating partici-
pants endorsed Item 135 (“Do you spend much time
worrying about your physical health? Would this aver-
age between 30 and 40 min each day?”), whereas none
of the adults with ADHD did. Adults with a genuine
presentation of ADHD did not endorse any of the
remaining items on this scale either, while approxi-
mately 5–18% of simulators did. Classiﬁcation accuracy
of the OS scale, as determined through an ROC analy-
sis, was nonetheless unsatisfactory. At an adequate
speciﬁcity of 97.8%, the sensitivity of this scale
amounted to 57.9%.
Neither the OS scale, nor the SIRS-2 in its entirety,
are suitable as sole means of detecting feigned instances
of adult ADHD. They may, however, present invaluable
starting points for the development of a disorder-speciﬁc
instrument. Based on the present ﬁndings, items of such
an instrument could tap highly speciﬁed symptoms
which appear relevant to ADHD to those who aim to
simulate the disorder. Examining simulators’ endorse-
ment of individual SIRS-2 items suggests that they deem
item number 135 more applicable to ADHD than other
items based on the same detection strategy. Few simu-
lators, for instance, endorsed items 24 (“Do you have
exactly two nightmares every evening?”) or 41 (“Do you
hear unnatural sounds or voices? Do they come from
closets and nowhere else?”), which apparently bear little
relevance to ADHD. Clearly, the item content of such a
disorder-speciﬁc instrument should be coherent with
peoples’ understanding of the condition.
Alongside items based on highly speciﬁc symptoms,
a disorder-speciﬁc instrument for the detection of
simulated ADHD could further proﬁt from a second
detection strategy employed in the SIRS-2. The primary
scale aiming to identify simulators based on their
endorsement of uncommon symptom combinations
(SC) narrowly failed to meet Roger’s standard of mod-
erate eﬀects between genuine and simulated instances
of ADHD in this study. Inquiries such as, “Do you
have a need to wash your hands frequently? Is this
related to any unique or special powers that you pos-
sess?” (Item 50) or “Do you have strong religious
thoughts and periods of giggling? Do these happen
together?” (Item 67) may not have struck participants
as immediately relevant to ADHD. If adapted to
ADHD-speciﬁc symptoms, such as instances of inat-
tention, hyperactivity, and impulsivity, this unlikely
detection strategy may nonetheless be of great value.
The use of unlikely detection strategies in uncover-
ing feigned ADHD has previously been advocated
based on promising results found across numerous
studies (see also Harrison, 2006). Suhr and colleagues
(Suhr, Buelow, et al., 2011), for example, developed an
infrequency index for the Conner’s Adult ADHD
Rating Scales (Conners et al., 1999), aiming to detect
simulated ADHD by means of a self-report question-
naire commonly used in clinical practice. To this end,
Suhr and colleagues determined which CAARS items
were rarely ever endorsed by genuine patients with
ADHD as well as non-treatment seeking adults. This
approach is arguably very akin to Roger’s concept of
unlikely detection strategies and has proven promising
in later studies (Cook et al., 2016). Even so, this index
was derived solely through statistical means, and its
sensitivity may be limited (Fuermaier et al., 2016a).
Limitations and future directions
This study employed a simulation design, which has been
criticized for its questionable ecological validity (Rogers,
2008a). The motivation of and incentives provided to
participants as part of this study are hardly comparable
to those faced by individuals who intend to simulate
ADHD in real life (Rogers et al., 1993). The current
ﬁndings should thus be followed up by studies using
known-groups comparisons (Rogers, 2008c). However,
participants who were asked to simulate adult ADHD as
part of this study were veriﬁably motivated to do so
convincingly. Each of them was able to correctly answer
questions regarding the simulation instructions and
further assured that they had followed these instructions
throughout the experiment upon its completion. Lastly,
responses provided by simulating participants diﬀered
signiﬁcantly from those of honest responding control
participants, suggesting that the instruction to feign
ADHD altered their response style (p < .001 for all com-
parisons but the DA scale for which p = .018; 0.46 < d <
2.86). Furthermore, participants’ performance on the
GET, a performance validity test, was considered before
including them in further analyses. The SIRS-2, on the
other hand, is a measure of symptom validity rather than
performance validity. As tests of performance validity and
symptom validity have been shown to yield diverging
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results (Hirsch & Christiansen, 2018), participants in
future studies should complete both a performance valid-
ity and a symptom validity test prior to the inclusion of
their data in further analyses.
Conclusions
The present results strongly advise against reliance on
the SIRS or SIRS-2 in the detection of feigned ADHD.
Whereas application of the original SIRS’ decision rules
resulted in acceptable sensitivity and unacceptably low
speciﬁcity rates, its successor’s decision model fared
poorly at the detection of feigned ADHD. Speciﬁcity
of the SIRS-2, on the other hand, was high. These
ﬁndings extend upon recent studies reporting signiﬁ-
cantly reduced sensitivity when the SIRS and SIRS-2
are compared (Brand et al., 2014; Green et al., 2013;
Tarescavage & Glassmire, 2016; Tylicki et al., 2018).
Additionally, they are in line with the developer’s cau-
tions (Rogers et al., 2010) which draw attention to the
distinction between the detection of feigned mental
disorders versus feigned cognitive complaints. The
developers underscore the SIRS’ utility in uncovering
feigned psychiatric symptoms, while the instrument
was not designed to detect feigning of the predomi-
nantly cognitive complaints manifesting in ADHD.
Whereas neither the SIRS-2’s classiﬁcation scheme
nor individual scales result in satisfactory classiﬁcation
accuracy, the detection strategies employed in the
interview may present useful starting points for the
development of a disease-speciﬁc symptom validity
measure. Items of such a measure may present exam-
inees with symptoms commonly occurring as part of
ADHD’s clinical manifestation, yet specify these to a
degree not usually reported by genuine patients.
Symptoms deemed representative of ADHD by laypeo-
ple might further be combined to construct disorder-
speciﬁc items resembling those of the SIRS-2’s SC scale.
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